StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Outside the United States by Year

Outside the United States (Ex-U.S. total net product revenues, $M) ($M)

Vertex Pharmaceuticals Outside the United States: $4,453M in FY2025, up 2.7% from a year earlier. That is the highest of the 15 years on record here.

Latest, FY2025
4,453
Period ended Dec 31, 2025
Change on a year earlier
+2.7%
4,335 in FY2024
History
15 years
Since FY2011
Sources
11
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-Q / 10-K Segment & Geographic Information Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOutside the United States (Ex-U.S. total net product revenues, $M) ($M)Year on yearSource
FY2025Dec 31, 20254,453+2.7%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20244,335+13.2%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 20233,829+18.5%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 20223,231+41.3%Form 10-K (filed 2025-02-13) ↗
FY2021Dec 31, 20212,286+66.1%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 20201,376+25.1%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 20191,100+61.2%Form 10-K (filed 2022-02-09) ↗
FY2018Dec 31, 2018683+36.0%Form 10-K (filed 2021-02-11) ↗
FY2017Dec 31, 2017502+31.9%Form 10-K (filed 2020-02-13) ↗
FY2016Dec 31, 2016380+41.4%Form 10-K (filed 2019-02-13) ↗
FY2015Dec 31, 2015269+22.7%Form 10-K (filed 2018-02-15) ↗
FY2014Dec 31, 2014219-30.4%Form 10-K (filed 2015-02-13) ↗
FY2013Dec 31, 2013315+105.2%Form 10-K (filed 2014-02-11) ↗
FY2012Dec 31, 2012154+627.5%Form 10-K (filed 2014-02-11) ↗
FY2011Dec 31, 201121.1–Form 10-K (filed 2014-02-11) ↗

Breakdown

What makes up outside the United States

Cite this data

StockData. (2026). Vertex Pharmaceuticals Outside the United States ($M), annual FY2011–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-geo-non-us

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.